Format

Send to

Choose Destination
See comment in PubMed Commons below
Diabetes Res Clin Pract. 2008 Dec 15;82 Suppl 2:S118-21. doi: 10.1016/j.diabres.2008.09.051. Epub 2008 Nov 22.

Continuous glucose monitoring in type 2 diabetes.

Author information

  • 1Department of Internal Medicine C and Diabetes Unit, Soroka University Medical Center, Beer-Sheva 84101, Israel. ilanahb@bgu.ac.il

Abstract

The utility and efficacy of self-monitoring of blood glucose (SMBG), using single capillary glucose determinations, in the management of non-insulin treated type 2 diabetes has been called into question. The use of continuous sub-cutaneous glucose monitoring (CGM) systems provides an answer for at least some of the inadequacies attributed to point capillary SMBG. The use of CGM adds information on postprandial glucose excursions, nocturnal hypoglycemia or hyperglycemia not previously detected by SMBG. This added information facilitates the tailoring of treatment regimens to the individual patient in order to achieve treatment targets without incurring an increased risk of hypoglycemia and provides a useful tool for patient self-management education.

[PubMed - indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Elsevier Science
    Loading ...
    Write to the Help Desk